|
Contents |
|
|
|
|
|
|
Cancer
Research |

|
|
|
|
M. Llanos Casanova, Cristina Blázquez, Jesús
Martínez-Palacio, Concepción Villanueva, M. Jesús
Fernández-Aceñero, John W. Huffman, José L. Jorcano
and Manuel Guzmán
Inhibition of skin tumor growth and angiogenesis in vivo by activation of
cannabinoid receptors
J. Clin. Invest. January 1 2003,
111:43-50. ( PDF Full Text)
|
|
|
Manuel
Guzmán
Cannabinoids: potential anticancer agents
Nature Reviews Cancer 3,
745-755 (October
2003) | doi:10.1038/nrc1188
Abstract |
Reprint
|
|
Thomas W. Klein, Cathy Newton, Kellie
Larsen, Lily Lu, Izabella Perkins, Liang
Nong and Herman Friedman
The cannabinoid system and immune modulation
Journal of Leukocyte Biology. 2003, October 1;74:486-496
|
|
|
Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar
H
Cannabinoids for cancer treatment: progress and promise
Cancer Res. 2008
Jan 15;68(2):339-42
Abstract |
Reprint
|
|
|
Glioblastoma |

|
|
|
|
Marcu
JP, Christian RT, Lau D, Zielinski AJ, Horowitz MP, Lee J, Pakdel A, Allison
J, Limbad C, Moore DH, Yount GL, Desprez PY, McAllister SD
Cannabidiol Enhances the Inhibitory Effects of {Delta}9-Tetrahydrocannabinol
on Human Glioblastoma Cell Proliferation and Survival
Mol Cancer Ther. 2010 Jan 6;. [Epub ahead of print]
Abstract
|
|
|
Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra
S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against
Glioma.
Mol Cancer Ther. 2011 Jan;10(1):90-103.
Abstract |
Related articles
|
|
|
Gliomas |

|
|
|
|
Aguado
T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzmán
M, Galve-Roperh I
Cannabinoids induce glioma stem-like cell differentiation and inhibit
gliomagenesis
J Biol
Chem. 2007 Mar 2;282(9):6854-62.
Epub 2007 Jan 2
Abstract |
Full Text |
Reprint
|
|
|
Cristina Blázquez, María
Salazar, Arkaitz Carracedo, Mar Lorente, Ainara
Egia, Luis González-Feria, Amador Haro, Guillermo
Velasco and Manuel Guzmán
Cannabinoids inhibit glioma cell invasion by down-regulating matrix
metalloproteinase-2 expression
Cancer Res. 2008 Mar 15;68(6):1945-52
Abstract |
Reprint
|
|
Blazquez C, Gonzalez-Feria L, Alvarez L, Haro A, Casanova ML, Guzman
M
Cannabinoids inhibit the vascular endothelial growth factor
pathway in gliomas
Cancer Res. 2004 Aug 15;64(16):5617-23
|
|
|
Cristina Blázquez, M. Llanos Casanova, Anna Planas, Teresa Gómez del
Pulgar, Concepción Villanueva, María J. Fernández-Aceñero, Julián
Aragonés, John W. Huffman, José L. Jorcano, and Manuel Guzmán
Inhibition of tumor angiogenesis by cannabinoids
The FASEB Journal. 2003
March;17:529-531. Published online January 2, 2003. (PDF Full Text)
|
|
|
Carracedo A, Geelen MJ, Diez M, Hanada
K, Guzman M, Velasco G
Ceramide sensitizes astrocytes to
oxidative stress: protective role of cannabinoids
Biochem J. 2004 Jun 1;380(Pt 2):435-40.
|
|
|
Duntsch
C, Divi
MK, Jones
T, Zhou
Q, Krishnamurthy
M, Boehm
P, Wood
G, Sills
A, Ii
BM
Safety and efficacy of a novel cannabinoid
chemotherapeutic, KM-233, for the treatment of high-grade glioma
J
Neurooncol. 2005 Nov 29;1-10 [Epub ahead of print].
|
|
Held-Feindt J, Dorner L, Sahan G, Mehdorn HM, Mentlein
R.
Cannabinoid receptors in human astroglial
tumors.
J Neurochem.
2006 Aug;98(3):886-93.
Abstract
|
|
|
Teresa Gómez del Pulgar, María L. de
Ceballos, Manuel Guzmán, and Guillermo Velasco
Cannabinoids Protect Astrocytes
from Ceramide-induced Apoptosis through the Phosphatidylinositol
3-Kinase/Protein Kinase B Pathway
J. Biol. Chem., Vol. 277, CNO 39, 36527-36533, September 27, 2002. (PDF Full Text)
|
|
|
Stig O. P. Jacobsson
, Thomas Wallin and Christopher J.
Fowler
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and
Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid
Receptors
J. Pharmacol. Exp. Ther., Vol. 299, CNO 3, 951-959, December 2001. (PDF Full Text)
|
|
|
Paola Massi, Angelo Vaccani, Stefania
Ceruti, Arianna Colombo, Maria P. Abbracchio,
and Daniela Parolaro
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human
Glioma Cell Lines
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 838 - 845.
|
|
|
Cristina Sánchez, María
L. de Ceballos, Teresa Gómez del
Pulgar, Daniel Rueda, César
Corbacho, Guillermo Velasco, Ismael Galve-Roperh,
John W. Huffman, Santiago Ramón y Cajal and Manuel
Guzmán
Inhibition of Glioma Growth in Vivo by Selective Activation of
the CB2 Cannabinoid Receptor
Cancer Research, 61, 5784-5789, August 1, 2001. (Full Text)
|
|
Velasco G, Galve-Roperh I, Sanchez C, Blazquez C, Guzman
M
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Neuropharmacology. 2004 Sep;47(3):315-23
|
|
|
Widmer M, Hanemann O, Zajicek J
High concentrations of cannabinoids activate apoptosis in human U373MG
glioma cells
J Neurosci Res. 2008 Jul 9; [Epub ahead of print]
Abstract
|
|
|
Nonsteroid
Anti-Infl Drugs |

|
|
|
|
Rene Anikwue, John W. Huffman, Zachary L. Martin and Sandra P.
Welch
Decrease in Efficacy and Potency of Nonsteroidal Anti-Inflammatory Drugs
by Chronic Δ9-Tetrahydrocannabinol Administration
J. Pharmacol. Exp. Ther., Vol. 303, CNO 1, 340-346, October 2002. (PDF Full Text)
|

|